Renalogic
Kevin brings a deep background in successfully growing investor-backed, innovative healthcare companies. Immediately prior to joining Renalogic, he was President of population health for a technology company, Azara Healthcare. Previously he has served as CEO and in other executive positions at a variety of pioneering healthcare companies including Allscripts (NASDAQ: MDRX), ZirMed (now Waystar), and Valence Health (now part of Evolent Health (NYSE: EVH). Kevin joined Renalogic in July 2021 and serves on the company’s Board of Directors.
This person is not in any offices
Renalogic
Risk Management for Kidney Diseases from prevention with clinical outreach to cost containment of unreasonably high dialysis cost claims.